CBD-Intel regulatory news in brief, 8th-14th May

Written by CBD-Intel || 14th May 2021 || Regulatory alerts roundup | Regulation and Legislation | Geographies: Alaska Asia Australasia Austria California China Europe Georgia Germany Greece Japan Louisiana Malta Minnesota Nebraska New Zealand North America North Carolina Panama South America Spain Tennessee Texas United Kingdom United States Uruguay

This week's regulatory news in brief includes updates from Austria, Germany, Greece, Malta, Spain, the UK, the US, China, Japan, New Zealand, Panama and Uruguay ...

Restricted content. Do you want to read more?

Subscribers: Login here

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Restricted content. Do you want to read more?

Register

Visit store

Read related content from CBD-Intel

Featured topic

Sign up to our newsletter

Subscribe for the latest industry updates

Start your FREE trial